Angiotensin Converting Enzyme Inhibitor, BPP 9a is a peptide analog derived from bradykinin-potentiating sequences that influence conformation and residue packing. It supports studies of catalytic recognition and interaction motifs. Its properties allow detailed mapping of peptide-enzyme surfaces. Applications include structure-activity research and synthetic peptide design.
CAT No: A15013
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More